Hjem › Psoriasisartrit › Ohio
Psoriasisartrit kliniske forsøg i Ohio
14 studier for Psoriasisartrit søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 3
Alder 3 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Paramount Medical Research & Consulting, Middleburg Heights
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07321873Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Middleburg Heights
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07286058A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 1. sep. 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Metrohealth Medical Center, Cleveland
- og 2 flere
RekruttererObservationsstudie
Op til 21 år · Alle køn · Opdateret 27. aug. 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 144, Vandalia
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. jul. 2026 · NCT07290036A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 3. apr. 2026 · NCT06454188Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Paramount Medical Research and Consulting /ID# 272757, Middleburg Heights
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. dec. 2025 · NCT06865105Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Cincy Arthritis, Blue Ash
- Southern Ohio Rheumatology, Wheelersburg
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 9. okt. 2025 · NCT05669833IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
RekruttererObservationsstudie
Alder 18 til 70 · Alle køn · Opdateret 29. jun. 2023 · NCT05883371Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.